|
Maintenance therapy Clinical Trials
2 actively recruiting trials
▲ +1 trial since March 2026
Pipeline
Phase 2: 1
Top Sponsors
- Shandong Cancer Hospital and Institute1
- Institute of Hematology & Blood Diseases Hospital, China1
Indications
- Cancer2
- Pancreatic Cancer Non-resectable1
- Acute Lymphoblastic Leukemia, Adult1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.